Copper plays a central role in conserved processes such as respiration, and in highly specialized processes, such as protein modification. The metalloprotease neprilysin (NEP) degrades a variety of bioactive peptides and is involved in many physiological processes.
INTRODUCTION
Most Alzheimer's disease (AD) cases occur randomly in the population, and many risk factors might be involved in the development of AD. A number of metal ions have been found to be risk factors associated with the pathogenesis of AD. For example, aluminum in drinking water has been reported to increase the risk of AD [1] , and the neuronal toxicity of amyloid-β (Aβ) is partly mediated by interaction of the peptide with iron [2] . Among these biometals, the most important and complicated one is copper. There is considerable evidence that the homeostasis of copper and several metalloproteinases is disturbed in AD [3, 4] . Serum and cerebrospinal fluid (CSF) copper levels have been reported to be elevated in AD patients [5, 6] , while the activities of some copper-dependent enzymes show the opposite trend to copper level. For examples, cytochrome C-oxidase and peptidylglycine α-amidating monooxygenase show decreased activities in AD patients [3, 7] . Copper can bind to histidine residues of Aβ, accelerate the aggregation of Aβ, and subsequently mediate the neurotoxicity of the peptide [8] [9] [10] [11] [12] .
Copper is an essential transition biometal and is a co-factor for a number of metalloenzymes.
Neprilysin (NEP, EC 3.4.24.11) is a metalloprotease which is involved in many physiological processes, such as neuropeptide metabolism, inflammation, cell migration, and proliferation [13, 14] . NEP has wide regulatory activities and degrades a variety of bioactive peptides, such as enkephalin and Aβ [14] . The involvement of NEP in Aβ degradation was first reported by Howell and colleagues [15] . Subsequently, using mouse models it was found that NEP is the major Aβ degrading enzyme in the brain [14, 16] . 4 However, very little is known about the regulation of NEP activity, or the relationship between copper and NEP. In this study, we report that Cu 2+ suppresses endogenous NEP activity in a dose-dependent manner and that the downregulation of NEP protein is mediated by the proteasome pathway.
MATERIALS AND METHODS

Reagents
Copper chloride (CuCl 2 ), thiorphan, Succinyl-Ala-Ala-Phe-7AMC, phosphoramidon, and microsomal leucine aminopeptidase were obtained from Sigma-Aldrich (St. Louis, MO, USA).
The protease inhibitor cocktail "Complete, EDTA-free" was purchased from Roche Diagnostics (Mannheim, Germany) and MG132 from Calbiochem (San Diego, CA, USA). Wild type mouse neuroblastoma N2a cells and WT-7 cells (N2a cells stably expressing both Swedish mutant APP695 and human wild-type PS1) were kindly provided by Drs. Sangram S. Sisodia (University of Chicago) and maintained as described previously [17] .
Copper treatment
Since Cu 2+ has been commonly used at a concentration of 10 µM in similar studies [18] , we first performed a time course experiment (0, 24, 48, and 72 h) using 10 µM Cu 2+ . A dose curve experiment was performed by incubating cells with different concentrations of Cu 2+ (0, 2.5, 10, and 30 µM) at 37°C for 48 h.
5
NEP enzymatic activity assay
Cells were plated in 6 well-plates. After treatment with Cu 2+ , the medium was removed, and cells were rinsed with PBS buffer. 200 µl of 2-(N-morpholino) ethanesulfonic acid (MES) buffer containing 1% Triton X-100 was then added, and cells were incubated for 15 min on ice as described previously [19, 20] . Cells were then scraped and homogenized by passing them 
Western blot analysis
Western blot analysis was carried out as previously described [19] [20] [21] 
RT-PCR analysis
Total RNA was extracted with TRIZOL (Invitrogen) and converted to cDNA by reverse transcriptase using random hexamers to prime superscript III RNasefree reverse transcriptase for 1 min, and 68°C for 2 min during 40 cycles, followed by a final extension of 7 min at 68°C [20] . The resulting PCR products were analyzed on a 1% agarose gel stained with ethidium bromide.
Aβ quantification
The levels of Aβ 40 in conditioned medium were measured with an ELISA kit (BIOSOURCE Immunoassay Kit), according to the manufacturer's instructions. Medium samples were co-incubated with a rabbit antibody against Aβ 40 in the Kit plates with 3 h shaking. Media samples were then removed and secondary antibody was added. Aβ 40 was finally quantified by a color reaction using a plate reader (Bio-Rad, Model 680).
Statistical analysis
Data were calculated as a proportion of the control value and expressed as mean ± S.E.
Comparisons between multiple groups were made by one-way ANOVA followed by Dunnett's Multiple Comparison Test, and the Student's t test was used for comparisons between two groups (confidence limits of p<0.05). All statistical analyses were performed using Prism 4.0 software.
RESULTS
Copper downregulated neprilysin activity
In order to investigate whether Cu 2+ is involved in regulating NEP activity, WT-7 cells were treated with 10 µM Cu 2+ for different time periods. After 24 h, 48 h, and 72 h of treatment, cells were harvested and NEP activity was measured by fluorimetric assay. As shown in Fig. 1A Fig. 1D , the addition of BCS blocked the Cu 2+ induced decrease in NEP activity (compare third and second columns, Fig. 1D ). To further determine the specificity of the Cu 2+ induced decrease in NEP activity, we also treated the cells with magnesium chloride and we found that Mg 2+ had no effect on NEP activity (Fig. 1E ).
Copper caused a dose-dependent increase in secreted Aβ
Since NEP is one of the major Aβ-degradation enzymes previously reported [14] , we next examined the effect of Cu 2+ treatment on the level of Aβ. WT-7 cells were treated with 2.5 µM and 10 µM Cu 2+ for 48 h. Aβ 40 secreted into the media was determined by ELISA. As shown in Fig. 1F , treatment with Cu 2+ resulted in a dose-dependent increase in the levels of Aβ 40 in the media, and this finding is in agreement with the decrease in NEP activity. We also examined the effect of Cu 2+ on the expression of AβPP and found that treatment with Cu 2+ had no effect on AβPP processing (data not shown).
Copper caused a decrease in neprilysin protein level but had no effect on mRNA level followed by Western blotting analysis. As shown in Fig. 2A 6, Fig. 3 ). However, the lysosomal protease inhibitor chloroquine did not block Cu 2+ -induced NEP degradation. It is also observed that the NEP protein levels in MG132-and lactacystin-treated cells were higher than that in cells without treatment with these inhibitors.
Taken together, these results indicate that the turnover or degradation of NEP protein is mediated by proteasome pathway. These data further strongly argue that the Cu
2+
-induced decrease in NEP activity is a result of enhanced turnover or degradation of NEP protein, mediated by proteasomes.
DISCUSSION
It is recognized that copper plays a role in normal metabolism and in certain pathophysiologic conditions. Elevated extracellular copper has been demonstrated in the brain in AD [4] , however, the question as to whether and how the elevated Cu 2+ contributes to the disease development remains elusive. In this study, we examined the effect of Cu 2+ on the activity of NEP, which is believed to be one of the major Aβ degradation enzymes, and found that treatment with Cu 2+ caused a marked decrease in NEP activity. The normal concentration of Cu 2+ in CSF is from 0.01 to 5.7 µM [22] , and in AD patients this level increased [5] . Therefore in our study, we used the concentrations of 2.5, 10, and 30 µM of Cu 2+ , which are in the range of the concentrations of Cu 2+ found under the disease conditions. It has been reported that at equilibrium, two to three copper ions (II) bind stoichiometrically to proteinase K (EC 3.4.21.14)
and abolish its activity [23] . Our findings provide another example of copper directly affecting the activity of proteinase.
To address the question as to how Cu 2+ causes a decrease in NEP activity, our data demonstrate that Cu 2+ causes a significant decrease in the NEP protein level. Moreover, our data clearly indicate that the decrease in NEP protein level caused by Cu 2+ treatment is not due to downregulation of NEP gene expression, but is instead due to enhanced turnover or degradation of NEP protein. There are two main pathways for physiologic protein degradation, namely the lysosome and proteasome pathways. In this study, by testing the proteasome-specific inhibitors MG132, and lactacystin and the lysosome inhibitor chloroquine, we demonstrated that Cu 2+ -induced degradation of NEP was mediated by a proteasome pathway. Proteasome is one of the major intracellular devices in which damaged or unneeded proteins are broken down.
Proteasome deals primarily with endogenous proteins that were synthesized within the cells but 13 folded incorrectly because of translation errors or other factors that cause posttranslational conformational changes of protein leading to its misfolding. There are two possibilities regarding the mechanism by which high dose of Cu 2+ causes proteasomal degradation of NEP. One possibility is that Cu 2+ directly binds to NEP and causes a conformational change on NEP and increases its susceptibility to proteasomal degradation; the other possibility is that treatment with Cu 2+ results in an increase in proteasome activity, leading to accelerated turnover of NEP.
However, at the present time, these possibilities are awaiting further examination in the future study. Recent studies have reported that copper posttranslationally regulates the levels of several proteins. Copper has been reported to stimulate the degradation of the copper chaperone of SOD1 protein, and this can be blocked by the proteasome inhibitors MG132 and lactacystin, but not by a cysteine protease inhibitor or inhibitors of the lysosomal degradation pathway [18] . The copper transporter protein hCtr1 is also posttranslationally regulated by copper. Elevated copper stimulates rapid endocytosis and degradation of hCtr1 [24] . Our study provides another example of a protein whose level is posttranslationally modulated by copper.
NEP is one of the most important enzymes involved in Aβ degradation. In this regard, it is particular interesting to note that treatment of cells with Cu 2+ resulted in an increase in secreted Aβ. It is very likely that this increase in secreted Aβ upon Cu 2+ treatment is a result of downregulation of NEP activity. Using a rabbit model it has been reported that copper introduced into the drinking water could induce Aβ plaque formation and learning deficits [25] . Moreover, several studies showed that elevation of serum free copper is correlated with cognitive decline in 14 AD [26, 27] . However, the mechanism by which copper regulates Aβ levels in such cases remains elusive. One possibility is that copper and zinc ions bind to Aβ and rapidly precipitate
Aβ. Another possibility is that depletion of these biometals results in dissolution of Aβ deposits, and their degradation [10, [28] [29] [30] . The results which we report here raise another possibility, that copper may regulate Aβ levels by modulating the activity of the Aβ degradation enzyme NEP.
Many studies have reported the effect of Cu 2+ on the pathogenesis of AD, however, the results are controversial. An increased extracellular copper has been reported in the brain of AD [4] and depletion of copper has been shown to downregulate expression of the AβPP gene [31] ;
whereas, other studies reported that copper inhibited Aβ production, possibly by altering the AβPP processing pathway [32] and that elevated intracellular level of copper caused reduction of Aβ likely due to upregulation of matrix metalloproteases in Chinese hamster ovary cells [33, 34] .
The discrepancy of these observations may be due to different cell types respond differently to copper treatment.
In summary, we report for the first time that copper downregulates endogenous NEP activity.
Moreover, our data demonstrate that copper suppresses NEP protein levels by modulating NEP degradation through a proteasome pathway. These results suggest a novel mechanism to explain how copper homeostasis affects the activity of metalloprotease and open a new avenue for studying the role of copper in amyloidosis in AD. 
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